Inhibrx Biosciences (INBX) FCF Margin (2023 - 2025)
Inhibrx Biosciences (INBX) reported FCF Margin of 2305.69% for Q2 2025, up 5495231.0% year-over-year from N/an in Q2 2024, and up 94.73% quarter-over-quarter from 43736.0% in Q4 2024.
Inhibrx Biosciences (INBX) FCF Margin (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has 3 years of FCF Margin data on file, last reported at 2305.69% in Q2 2025.
- FCF Margin for Q2 2025 came in at 2305.69%, up 5495231.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 9273.21% (up 146866.0% YoY), and the FY2025 annual result was 9986.54%, up 8851646.0% from the prior year.
- FCF Margin advanced to 2305.69% in Q2 2025 per INBX's latest filing, from 43736.0% in the prior quarter.
- Over five years, FCF Margin peaked at 2305.69% in Q2 2025 and troughed at 57258.0% in Q2 2024.
- A 3-year average of 30650.66% and a median of 43736.0% in 2024 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2024 and 2025: FCF Margin tumbled 4004793 bps in 2024, then jumped 5495231 bps in 2025.
- A 3-year view of FCF Margin shows it stood at 3688.07% in 2023, then sank by 1086 bps to 43736.0% in 2024, then jumped by 95 bps to 2305.69% in 2025.
- Business Quant data shows INBX's FCF Margin at 2305.69% in Q2 2025, 43736.0% in Q4 2024, and 57258.0% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Inhibrx Biosciences | 186.16 Mn | 186.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -2,305.69% |
| Dec 31, 2024 | -43,736.00% |
| Jun 30, 2024 | -57,258.00% |
| Dec 31, 2023 | -3,688.07% |
| Sep 30, 2023 | -46,265.55% |